ALKBH5 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), ALKBH5 has been found to inhibit TGF-β-induced epithelial-mesenchymal transition (EMT) by regulating the TGF-β/SMAD signaling pathway, thereby suppressing tumor invasion and metastasis53.